Skip to main content
Podcasts

Reducing Hospitalizations for OAs Over 65 Years of Age in NHs


March 03, 2021

Gregg Sylvester, MD, MPH, chief medical officer, SeqirusGregg Sylvester, MD, MPH, chief medical officer, Seqirus, explains why the use of Fluad (Influenza Vaccine, Adjuvanted) was more effective than non-adjuvanted standard dose trivalent influenza vaccine for reducing the risk of all-cause hospitalizations, as well as hospitalization for influenza and pneumonia, among adults 65 years of age and older living in nursing homes, based on data published online in Clinical Infectious Diseases. 

Reference:

Gravenstein S, McConeghy KW, Saade E, et al. Adjuvanted influenza vaccine and influenza outbreaks in U.S. nursing homes: Results from a pragmatic cluster-randomized clinical trial [published online ahead of print, 2021 Jan 5]. Clin Infect Dis. 2021;ciaa1916. doi:10.1093/cid/ciaa1916 

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
7 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top